Sunday, July 5, 2026
ADVT 
National

Lululemon says Omicron impacting sales, profits

Darpan News Desk The Canadian Press, 10 Jan, 2022 04:54 PM
  • Lululemon says Omicron impacting sales, profits

VANCOUVER - Lululemon Athletica Inc. is lowering its fourth-quarter earnings estimates as the Omicron variant curbs the retailer's sales.

The Vancouver-based company says it now expects its net revenue and earnings to be on the low end of previously announced ranges.

Calvin McDonald, CEO of the athletic apparel retailer, says Lululemon started the holiday season in a strong position.

But he says the company has since experienced several consequences as a result of the surge in COVID-19 cases and changing restrictions.

He says Lululemon has been impacted by increased capacity constraints in stores, more limited staff availability and reduced operating hours in some locations.

David Swartz, an equity analyst at Morningstar, says Lululemon has consistently smashed sales and earnings expectations over the past three years, making it surprising to see any weakness emerge.

While he says one mild earnings miss does not materially impact valuation, the financial services firm has long had concerns that Lululemon is significantly overvalued

In a client note last March, Morningstar said Lululemon’s valuation "is as stretched as its leggings."

Lululemon’s share price dropped a little more than six per cent following Monday's announcement, and was down roughly 30 per cent from its all-time high in November.

The company's shares were trading for about US$333.30 midday on the Nasdaq composite. Swartz says Morningstar's fair value estimate is US$193.

Lululemon says it expects the company’s net revenue to be toward the low end of its range of US$2.125 billion to US$2.165 billion.

It expects diluted earnings per share and adjusted diluted earnings per share to be toward the low end of its ranges of US$3.24 to US$3.31 and US$3.25 to US$3.32, respectively.

MORE National ARTICLES

B.C. premier to undergo biopsy surgery

B.C. premier to undergo biopsy surgery
The premier says he won't step down and he plans to retain his position as the head of the Council of the Federation. He says as a precaution, Public Safety Minister Mike Farnworth has been appointed deputy premier to support him.

B.C. premier to undergo biopsy surgery

Another stranger assault in Dowtown Vancouver on a 23 year old female leaving a coffee shop:VPD

Another stranger assault in Dowtown Vancouver on a 23 year old female leaving a coffee shop:VPD
The troubling incident happened around 5:30 p.m. Wednesday, as the 23-year-old victim was leaving a coffee shop near Main and East Pender streets. The 35-year-old suspect is known to police. She was released from custody after agreeing to attend court at a later date.              

Another stranger assault in Dowtown Vancouver on a 23 year old female leaving a coffee shop:VPD

Canada leads G20 in financing fossil fuels: report

Canada leads G20 in financing fossil fuels: report
The report, which includes 2019 and 2020, adds up loans, loan guarantees, grants, share purchases and insurance coverage provided to fossil fuel producers by governments, government agencies and government-owned multinational development banks.

Canada leads G20 in financing fossil fuels: report

Study finds gaps in vendors' child labour policies

Study finds gaps in vendors' child labour policies
The report recommends several ways the government can work with suppliers to avoid complicity in human trafficking, forced labour and child labour, such as favouring companies with a clear understanding of the problems and appropriate policies to address them.

Study finds gaps in vendors' child labour policies

Vaccines, climate top Trudeau's agenda in Europe

Vaccines, climate top Trudeau's agenda in Europe
The study by Clean Prosperity published today could give some heft to Prime Minister Justin Trudeau's credentials as he heads to planned climate discussions at the upcoming G20 summit and United Nations COP 26 meeting.

Vaccines, climate top Trudeau's agenda in Europe

To boost biotech, fund best bets: Moderna founder

To boost biotech, fund best bets: Moderna founder
Derrick Rossi says Canadian politicians have a track record of trying to be equitable with their funding pledges to hit every region of the country. There is a political calculation behind that, he suggests, but setting the country up for long-run growth — especially in biotech — will require putting money behind the best bets and regions for growth of new firms.    

To boost biotech, fund best bets: Moderna founder